期刊文献+

表达及与临床病理学参数的关系浸润性乳腺癌中白细胞介素18和血管内皮生长因子的

The Correlation between Interleukin-18, Vascular Endothelial Growth Factor Expression and Clinicopathologic Parameters for Invasive Breast Cancer
原文传递
导出
摘要 目的通过检测浸润性乳腺癌中白细胞介素18(IL-18)和血管内皮生长因子(VEGF)的表达情况,探讨其表达相关性及与临床病理学参数的关系。方法应用免疫组织化学法检测IL-18和VEGF在42例浸润性乳腺癌组织和12例正常乳腺组织中的表达情况。结果 IL-18和VEGF在42例浸润性乳腺癌中的表达阳性率均显著高于12例正常乳腺组织(P<0.05)。且在42例浸润性乳腺癌组织中,IL-18阳性组中VEGF阳性率(87.1%)显著高于IL-18阴性组中VEGF阳性率(12.9%),差异有统计学意义(P<0.05)。在亚组分析中,IL-18的表达只与有无腋窝淋巴结转移有相关性(P<0.05),而VEGF的表达与有无腋窝淋巴结转移和TNM分期有相关性(P<0.05)。结论在浸润性乳腺癌中,IL-18的表达上调与VEGF的表达上调显著相关,IL-18可能具有促进肿瘤新生血管形成的作用。 Objective To study the correlation between interleukin-18 (IL-18) and vascular endothelial growth factor (VEGF) expression and their relationship with clinicopathologic parameters in patients with human invasive breast cancer. Methods Immunohistochemical technique was used to detect the expression of IL-18 and VEGF in 42 cases of invasive breast cancer tissues and 12 cases of normal mammary gland tissues. Results The positive rates of IL-18 and VEGF were significantly higher in invasive breast cancer tissues than those in normal mammary gland tissues (P 〈 0.05). In the 42 cases of invasive breast cancer tissues, positive rates of VEGF in 31 cases of positive IL-18 (87.1%) was significantly higher than that in 11 cases of negative IL-18 (12.9%) (P 〈 0.05). The expression of IL-18 was only correlated with the lymph node metastasis in invasive breast cancer cases (P 〈 0.05), while the expression of VEGF was correlated with both lymph node metastasis and TNM stage (P 〈 0.05). Conclusions The expression of IL-18 and VEGF are up- regulated correlatively. IL- 18 may participate in angiogenesis.
出处 《华西医学》 CAS 2012年第10期1458-1461,共4页 West China Medical Journal
关键词 乳腺癌 白细胞介素18 血管内皮生长因子 表达 Breast cancer Interleukin-18 Vascular endothelial growth factor Expression
  • 相关文献

参考文献25

  • 1Kim KE, Song H, Kim TS, et al. Intarleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines[J]. Oncogene, 2007, 26(10): 1468-1476. 被引量:1
  • 2Kang JS, Bae SY, Kim HR, et al. Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44[J]. Carcinogenesis, 2009, 30(12): 1987-1996. 被引量:1
  • 3Nong S J, Zhang YP, Zhou S J, et al. Relationship between serum IL-18 and VEGF levels in patients with prostate cancer[J]. Chinese- German J Clin Oncol, 2010, 9(11): 643-647. 被引量:1
  • 4Tsuboi K, Tatsuya M, Nakajima M, et al. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma[J]. Cancer Lett, 2004, 205(2): 207-214. 被引量:1
  • 5Jebreel A, Mistry D, Loke D, et al. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer[J]. J Laryngol Otol, 2007, 121(3): 246-252. 被引量:1
  • 6Park H, Byun D, Kim TS, et al. Enhanced IL-18 expression incommon skin tumors[J]. Immunol Lett, 2001, 79(3): 215-219. 被引量:1
  • 7Vidal-Vanaclocha F, Mendoza L, Telleria N, et al. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression[J]. Cancer Metastasis Rev, 2006, 25(3): 417-434. 被引量:1
  • 8Xia D, Zheng S, Zhang W, et al. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen[J]. J Mol Med, 2003, 81(9): 585-596. 被引量:1
  • 9Okamura H, Tsutsui H, Kashiwamura S, et al. Interleukin- 18: a novel cytokine that augments both innate and acquired immunity[J]. Adv Immnnol, 1998, 70: 281-312. 被引量:1
  • 10Marshall D J, Rudnick KA, Mccarthy SG, et al. Interleukin-18 enhances Thl immunity and tumor protection of a DNA vaccine[J]. Vaccine, 2006, 24(3): 244-253. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部